Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Palo Alto, USA
3181 Porter Drive
Palo Alto, CA, 94304
USA

People

Board of Directors

Funding

TOTAL $26M
FUNDING TOTAL $26M
Series B, 11/2007
Vivo Ventures
Alta Partners
InterWest Partners
$20M
Series C, 1/2013
Alta Partners
InterWest Partners
Vivo Ventures
$6M

Tags

Carbylan BioSurgery

Carbylan was founded in 2005 to develop and market medical devices and device/drug combination products based on chemically engineered polymers of hyaluronic acid, a well known polysaccharide widely present in the human body.

Its initial market focus is therapeutic medical devices for rhinosinusitis and osteoarthritis. Carbylan’s proprietary technology enables delivery of biomaterial-based medical devices as injectable liquids that self-polymerize inside the body to form therapeutic implants that covalently bind to tissues at the target delivery site.

Recent Milestones

Videos

Screenshots

Sources

  1. Carbylan Announces $20 Million Series B Financing (carbylan.com) [edit]
  2. Medical Device Daily: Med-Tech Notes - Carbylan BioSurgery, Inc. (altapartners.com) [edit]
Edit This Page
Last Edited 2/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy